CLOPILET A-150 – CAP
₹102.00
CLOPILET A-150 CAP is a combination capsule containing Clopidogrel 150 mg and Aspirin, designed to prevent blood clots and reduce the risk of heart attacks and strokes in high-risk cardiovascular patients by dual inhibition of platelet aggregation.
Description
CLOPILET A-150 CAP combines Clopidogrel 150 mg and Aspirin to provide a potent dual antiplatelet effect. Clopidogrel works by selectively inhibiting the ADP receptor on platelet surfaces, preventing platelet aggregation, while Aspirin irreversibly inhibits cyclooxygenase (COX) enzyme, reducing thromboxane A2 formation, another key factor in platelet activation.
This combined therapy is commonly prescribed for patients with acute coronary syndrome, recent myocardial infarction, ischemic stroke, or those who have undergone coronary artery stenting. The dual-action significantly lowers the risk of thrombotic cardiovascular events compared to monotherapy.
Patients should use CLOPILET A-150 CAP under medical supervision due to the increased risk of bleeding. Adherence to prescribed dosage and monitoring for any signs of bleeding or adverse reactions is essential for safe and effective treatment.
Reviews
There are no reviews yet.